
Patrik Jonsson, executive vice president and president, Lilly International, will retire at the end of 2026

Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashes

The deal focuses on addressing critical unmet medical needs

The acquisition is to advance treatments for serious autoimmune and allergic diseases

The UK is the first country in Europe to authorise the oral medication

The treatment is to protect children under two years of age from respiratory syncytial virus

Around 60,000 people in the US get pancreatic cancer each year, with an estimated 50,000 deaths projected annually

The acquisition will advance therapies for treatment-resistant depression and other mental health conditions

This new option for patients allows for as few as six maintenance injections per year

The acquisitions reinforce the company’s commitment to reduce the long-term burden of serious disease

Hypertension affects more than 1.4 billion people worldwide and many patients remain uncontrolled despite multiple therapies

In 2026, an estimated 22,720 people in the US will be diagnosed with AML